6 completed, 5 terminated, 3 recruiting, 2 not yet recruiting. 21 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 21 | Completed 6, Terminated 5, Recruiting 3, Not yet recruiting 2, Unknown 2, Withdrawn 2, Active not recruiting 1 |
| Phase 1 | 2 | Terminated 2 |
| Phase 3 | 1 | Completed 1 |
Follow Transarterial chemoembolization: new trials by email Literature Review of Transarterial chemoembolization trials Research Report on Transarterial chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment Transarterial chemoembolization, durvalumab and tremelimumab - HCC, Tace | Phase 2 | Not yet recruiting | Chang Gung Memorial Hospital | 90 | 2027-02-01 | 2026-11-02 |
| Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer Transarterial chemoembolization - Unresectable Colorectal Cancer, Advanced Malignancy | Phase 2 | Not yet recruiting | Junpeng Wang | 50 | 2025-10-01 | 2025-10-07 |
| Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors Sulfur Hexafluoride Lipid Microspheres, Contrast-Enhanced Ultrasound, Transarterial Chemoembolization - Liver Neoplasms | Phase 2 | Recruiting | john eisenbrey | 266 | 2024-08-07 | 2026-02-17 |
| Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC Atezolizumab Injection, Bevacizumab, Transarterial chemoembolization - Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma | Phase 2 | Terminated | Yale University | 3 | 2023-06-07 | 2025-01-15 |
| Phase II Trial of Lung Chemoemobolization Computed Tomography, Ethiodized Oil, Mitomycin - Lung Non-Small Cell Carcinoma, Mediastinal Neoplasm | Phase 2 | Recruiting | City of Hope Medical Center | 30 | 2023-05-12 | 2026-03-05 |
| Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) Transarterial Chemoembolization - Gastric Cancer, Embolization | Phase 2 | Unknown | Gang Wu | 60 | 2022-06-01 | 2022-05-24 |
| A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection Tislelizumab, TACE - Hepatocellular Carcinoma, Adjuvant Therapy | Phase 2 | Unknown | Zhejiang University | 50 | 2021-11-08 | 2022-01-05 |
| Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases Carmustine, Ethiodized Oil, Transarterial Chemoembolization - Metastatic Malignant Neoplasm in the Liver, Metastatic Uveal Melanoma | Phase 2 | Active not recruiting | Thomas Jefferson University | 28 | 2021-09-27 | 2026-05-06 |
| Evaluate the Effect of Tirazamine on Primary Liver Cancer. tirapazamine, Transarterial Embolization, TACE - Hepato Cellular Carcinoma (HCC) | Phase 1 / Phase 2 | Terminated | Zhejiang Raygene Pharmaceuticals Co., Ltd | 16 | 2021-05-14 | 2025-02-27 |
| Perioperative Therapy for Hepatocellular Carcinoma Sintilimab Injection, TACE, Radiotherapy - Hepatocellular Carcinoma | Phase 2 | Terminated | Zhejiang University | 10 | 2020-12-26 | 2022-01-11 |
| Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma Nivolumab, Ipilimumab, Cabozantinib - Hepatocellular Carcinoma, HCC | Phase 2 | Recruiting | University of California, Irvine | 35 | 2020-08-07 | 2026-10-26 |
| Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver Bland Embolization, Transarterial chemoembolization, Drug Eluting Beads Embolization - Neuroendocrine Tumor, Malignant, Liver Metastases | Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 162 | 2016-03-01 | 2025-01-06 |
| HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B Hepatic arterial infusion, Transarterial chemoembolization, Folfox Protocol - Hepatocellular Carcinoma | Phase 2 | Completed | Sun Yat-sen University | 79 | 2015-10-01 | 2017-02-09 |
| Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma ADI-PEG 20, Transarterial chemoembolization - Unresectable Hepatocellular Carcinoma | Phase 2 | Completed | Polaris Group | 30 | 2014-10-15 | 2018-09-04 |
| TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer transarterial chemoembolization, stereotactic radiosurgery - Adult Primary Hepatocellular Carcinoma, Recurrent Adult Primary Liver Cancer | Phase 2 | Withdrawn | Case Comprehensive Cancer Center | 2014-04-01 | 2014-12-02 | |
| Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) Radiation therapy, Transarterial chemoembolization - Hepatocellular Carcinoma | Phase 2 | Withdrawn | Asan Medical Center | 2011-10-01 | 2014-06-26 | |
| Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer sunitinib malate, Placebo, transarterial chemoembolization - Liver Cancer | Phase 2 / Phase 3 | Completed | Federation Francophone de Cancerologie Digestive | 78 | 2010-07-01 | 2022-03-18 |
| Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma TACE, SBRT - Carcinoma, Hepatocellular, Hepatobiliary Neoplasm | Phase 1 / Phase 2 | Terminated | Stanford University | 11 | 2009-09-01 | 2016-07-27 |
| A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection epirubicin and lipiodol - Hepatocellular Carcinoma | Phase 2 | Completed | Eastern Hepatobiliary Surgery Hospital | 450 | 2009-01-01 | 2016-04-01 |
| Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC Sorafenib, TACE - Carcinoma, Hepatocellular | Phase 2 | Terminated | University of Pittsburgh | 19 | 2008-01-01 | 2017-02-15 |
Showing 20 of 21. Sign in to see all of them.
Carcinoma, Hepatocellular (13) · Liver Neoplasms (3) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Mediastinal Neoplasms (1) · Neuroendocrine Tumors (1) · Pleural Neoplasms (1) · Recurrence (1) · Sarcoma (1) · Stomach Neoplasms (1) · Uveal Melanoma (1)
Zhejiang University (2) · Abramson Cancer Center at Penn Medicine (1) · Asan Medical Center (1) · Case Comprehensive Cancer Center (1) · Chang Gung Memorial Hospital (1) · City of Hope Medical Center (1) · Eastern Hepatobiliary Surgery Hospital (1) · Federation Francophone de Cancerologie Digestive (1) · Gang Wu (1) · Junpeng Wang (1) · Polaris Group (1) · Stanford University (1) · Sun Yat-sen University (1) · Thomas Jefferson University (1) · University of California, Irvine (1)
United States (8) · China (5) · Argentina (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Taiwan (1)
Caifang Ni, M.D (1) · Carin Gonsalves, MD (1) · Daniel T Chang (1) · Farshid Dayyani, MD, PhD (1) · Franz E Boas, MD (1) · Han Chu Lee, M.D (1) · Jens Ricke, M.D. (1) · Juan Sanabria (1) · Michael C Soulen, MD, FSIR (1) · Ming Shi, MD (1) · Mohamed Hebbar, MD (1) · Pei-Jer Chen, MD, PhD (1) · Stacy Stein, MD (1) · Thomas C Gamblin, MD (1)
PMID 30016989, PMID 32576496, PMID 37611799
2005 (1), P30CA033572 (1), P30CA043703 (1), R01CA194307 (1)